TELA Bio, Inc. SEC filings TELA

TELA Bio, Inc. has 545 filings in SEC EDGAR's recent list, going back to Dec 6, 2012. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 8, 2026 (shareholder vote results). The company's fiscal year ends on December 31.

TELA Bio, Inc. SEC filings
Form Description Filed Period
DEF 14A Proxy statement Sep 14, 2026 Oct 8, 2026
PRE 14A Preliminary proxy statement Sep 4, 2026 Oct 8, 2026
DEFA14A Additional proxy material Apr 30, 2026 —
DEF 14A Proxy statement Apr 30, 2026 Jun 9, 2026
DEFA14A Additional proxy material Apr 17, 2025 —
DEF 14A Proxy statement Apr 17, 2025 May 28, 2025
PRE 14A Preliminary proxy statement Apr 7, 2025 May 28, 2025
DEFA14A Additional proxy material Apr 18, 2024 —
DEF 14A Proxy statement Apr 18, 2024 Jun 4, 2024
DEFA14A Additional proxy material Apr 17, 2023 —
DEF 14A Proxy statement Apr 17, 2023 Jun 1, 2023
DEFA14A Additional proxy material Apr 21, 2022 —
DEF 14A Proxy statement Apr 21, 2022 Jun 1, 2022
DEFA14A Additional proxy material Apr 22, 2021 —
DEF 14A Proxy statement Apr 22, 2021 Jun 2, 2021
DEFA14A Additional proxy material Apr 23, 2020 —
DEF 14A Proxy statement Apr 23, 2020 Jun 4, 2020

Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
TELA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Malvern, PA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1561921

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.